Adult ID

HIV/TB/STD

Global ID

Oral Abstract

198 - Tuberculosis: Stigma, Diagnosis, and Treatment

Presentations:

• 3:15 PM - 3:30 PM

  1882 - Tuberculosis in the Department of Veterans Affairs: Missed Opportunities for Prevention
  Gina Oda, MS, CIC – Department of Veterans Affairs; Cynthia Lucero-Obusan, MD, CIC – Department of Veterans Affairs; Patricia Schirmer, MD, CIC – Department of Veterans Affairs; Mark Holodniy, MD, CIC – Department of Veterans Affairs
• 3:30 PM - 3:45 PM

  1883 - Factors Associated with Stigma toward Isoniazid-Preventative Therapy in a Rural Community of South Africa
  Carlo F. Foppiano Palacios, MD – University of Maryland; Tejaswi Kompala, MD – University of California, San Francisco; Anthony Moll, MBChB – Church of Scotland Hospital; Laurie J. Andrews, RN MPH – Yale University; Sheela Shenoi, MD, MPH – Yale University
• 3:45 PM - 4:00 PM

  1884 - Clinical Outcomes among Patients with Drug-Resistant Tuberculosis receiving Bedaquiline or Delamanid Containing Regimens
  Russell R. Kempker, MD, MSc – Emory University; Lali Mikiashvili, MD – National Center for Tuberculosis and Lung Diseases; Yuan Zhao, MS – Emory University; David Benkeser, PhD – Emory University; Ketino Barbakadze, MD – National Center for Tuberculosis and Lung Diseases; Nino Bablishvili, PhD – National Center for Tuberculosis and Lung Diseases; Charles Peloquin, Pharm.D. – University of Florida; Henry Blumberg, MD – Emory University; Maia Kipiani, MD – National Center for Tuberculosis and Lung Diseases
• 4:00 PM - 4:15 PM

  1885 - T-Helper 1 (Th1) Production of Interferon Gamma (IFNγ) is Directly Inhibited by TGFβ Within Pulmonary Mycobacterium tuberculous (Mtb) Granulomas
  Benjamin H. Gern, MD – Seattle Children's Hospital; Kristin Adams, PhD – Seattle Children's Hospital; Caleb Stoltzfus, PhD – University of Washington; Courtney Plumlee, PhD – Seattle Children's Hospital; Michael Gerner, PhD – University of Washington; Kevin Urdahl, MD, PhD – Seattle Children's Hospital
• 4:15 PM - 4:30 PM

  1886 - N¹, N¹²-Diacetylspermine as Potential Urinary Biomarker to Monitor Treatment Response and Bacterial Load in Pulmonary Tuberculosis
  Qianjing (Jenny) Xia, BA – Weill Cornell Medicine; Myung Hee Lee, PhD – Weill Cornell Medicine; Kyu Rhee, MD, PhD – Weill Cornell Medicine; Flonza Isa, MD – Weill Cornell Medicine

Co-Author(s)

• KA

  Kristin Adams, PhD

  Research Scientist III
  Seattle Children's Hospital
  Seattle, WA

  Disclosure: Nothing to disclose
• TK

  Tejaswi Kompala, MD

  Clinical Fellow in Endocrinology
  University of California, San Francisco
  San Francisco, CA

  Disclosure: Nothing to disclose
• ML

  Myung Hee Lee, PhD

  Assistant Professor of Clinical Epidemiology in Medicine
  Weill Cornell Medicine
  New York, NY

  Disclosure: Nothing to disclose
• CL

  Cynthia Lucero-Obusan, MD, CIC

  Medical Epidemiologist
  Department of Veterans Affairs
  Palo Alto, CA

  Disclosure: Nothing to disclose
• LM

  Lali Mikiashvili, MD

  Physician
  National Center for Tuberculosis and Lung Diseases
  Tbilisi, Tbilisi, Georgia

  Disclosure: Nothing to disclose
• AM

  Anthony Moll, MBChB

  Senior Medical Officer
  Church of Scotland Hospital
  Tugela Ferry, KwaZulu-Natal, South Africa

  Disclosure: Nothing to disclose
• KR

  Kyu Rhee, MD, PhD

  Associate Professor of Medicine
  Weill Cornell Medicine
  New York, NY

  Disclosure: Nothing to disclose
• PS

  Patricia Schirmer, MD, CIC

  Medical Epidemiologist
  Department of Veterans Affairs
  Palo Alto, CA

  Disclosure: Nothing to disclose
• CS

  Caleb Stoltzfus, PhD

  Postdoctoral Scientist
  University of Washington
  Seattle, WA

  Disclosure: Nothing to disclose
• YZ

  Yuan Zhao, MS

  Student
  Emory University
  Atlanta, GA

  Disclosure: Nothing to disclose
• LA

  Laurie Andrews, RN MPH

  Program Manager
  Yale University
  Glastonbury, CT

  Disclosure: Nothing to disclose
• DB

  David Benkeser, PhD

  Assistant Professor
  Emory University
  Atlanta, GA

  Disclosure: Nothing to disclose
• MH

  Mark Holodniy, MD, CIC

  Director of Public Health Surveillance and Research
  Department of Veterans Affairs
  Palo Alto, CA

  Disclosure: Nothing to disclose
• FI

  Flonza Isa, MD

  Assistant Professor of Medicine
  Weill Cornell Medicine
  New York, NY

  Disclosure: Nothing to disclose
• CP

  Courtney Plumlee, PhD

  Research Scientist IV
  Seattle Children's Hospital
  Seattle, WA

  Disclosure: Nothing to disclose
• KB

  Ketino Barbakadze, MD

  Physician
  National Center for Tuberculosis and Lung Diseases
  Tbilisi, Tbilisi, Georgia

  Disclosure: Nothing to disclose
• MG

  Michael Gerner, PhD

  Assistant Professor
  University of Washington
  Seattle, WA

  Disclosure: Nothing to disclose
• SS

  Sheela Shenoi, MD, MPH

  Assistant Professor of Medicine
  Yale University
  New Haven, Connecticut

  Disclosure: Amgen Pharmaceuticals: Other Financial or Material Support, My spouse was a part time contractor for ProUnlimited LLC, through which he provided services to Amgen Pharmaceuticals from Oct 2015-Oct 2018.
• NB

  Nino Bablishvili, PhD

  Researcher
  National Center for Tuberculosis and Lung Diseases
  Tbilisi, Tbilisi, Georgia

  Disclosure: Nothing to disclose
• KU

  Kevin Urdahl, MD, PhD

  Professor
  Seattle Children's Hospital
  Seattle, WA

  Disclosure: Nothing to disclose
• CP

  Charles Peloquin, Pharm.D.

  Professor and Director, Infectious Disease Pharmacokinetics Laboratory
  University of Florida
  Gainesville, FL

  Disclosure: Nothing to disclose
• HB

  Henry Blumberg, MD

  Professor of Medicine
  Emory University
  Atlanta, GA

  Disclosure: Nothing to disclose
• MK

  Maia Kipiani, MD

  Researcher
  National Center for Tuberculosis and Lung Diseases
  Tbilisi, Tbilisi, Georgia

  Disclosure: Nothing to disclose

Moderator(s)

• 

  Jeffrey Tornheim, MD, MPH

  Assistant Professor of Medicine
  Johns Hopkins
  Baltimore, MD

  Disclosure: Nothing to disclose
• 

  Emily Kendall, MD, PhD

  Assistant Professor of Medicine
  Johns Hopkins
  Baltimore, MD

  Disclosure: Nothing to disclose

Presenting Author(s)

• CF

  Carlo Foppiano Palacios, MD

  Resident
  University of Maryland
  Baltimore, MD

  Disclosure: Nothing to disclose
• BG

  Benjamin Gern, MD

  Acting Instructor
  Seattle Children's Hospital
  Seattle, WA

  Disclosure: Nothing to disclose
• RK

  Russell Kempker, MD, MSc

  Associate Professor
  Emory University
  Atlanta, GA

  Disclosure: Nothing to disclose
• GO

  Gina Oda, MS, CIC

  Associate Director of Public Health Surveillance and Research
  Department of Veterans Affairs
  Palo Alto, CA

  Disclosure: Nothing to disclose
• QX

  Qianjing (Jenny) Xia, BA

  Medical Student
  Weill Cornell Medicine
  New York, NY

  Disclosure: Nothing to disclose